ACRS
Price
$3.51
Change
+$0.08 (+2.33%)
Updated
Jan 30 closing price
Capitalization
380.83M
30 days until earnings call
Intraday BUY SELL Signals
MAIA
Price
$2.41
Change
+$0.02 (+0.84%)
Updated
Jan 30 closing price
Capitalization
89.25M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACRS vs MAIA

Header iconACRS vs MAIA Comparison
Open Charts ACRS vs MAIABanner chart's image
Aclaris Therapeutics
Price$3.51
Change+$0.08 (+2.33%)
Volume$1.15M
Capitalization380.83M
MAIA Biotechnology
Price$2.41
Change+$0.02 (+0.84%)
Volume$541.72K
Capitalization89.25M
ACRS vs MAIA Comparison Chart in %
ACRS
Daily Signal:
Gain/Loss:
MAIA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACRS vs. MAIA commentary
Feb 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Hold and MAIA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 02, 2026
Stock price -- (ACRS: $3.51 vs. MAIA: $2.41)
Brand notoriety: ACRS and MAIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRS: 55% vs. MAIA: 49%
Market capitalization -- ACRS: $380.83M vs. MAIA: $89.25M
ACRS [@Biotechnology] is valued at $380.83M. MAIA’s [@Biotechnology] market capitalization is $89.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 1 FA rating(s) are green whileMAIA’s FA Score has 0 green FA rating(s).

  • ACRS’s FA Score: 1 green, 4 red.
  • MAIA’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRS is a better buy in the long-term than MAIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 5 TA indicator(s) are bullish while MAIA’s TA Score has 5 bullish TA indicator(s).

  • ACRS’s TA Score: 5 bullish, 5 bearish.
  • MAIA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MAIA is a better buy in the short-term than ACRS.

Price Growth

ACRS (@Biotechnology) experienced а -22.00% price change this week, while MAIA (@Biotechnology) price change was -5.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.27%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +33.81%.

Reported Earning Dates

ACRS is expected to report earnings on Mar 03, 2026.

MAIA is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (-4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACRS($381M) has a higher market cap than MAIA($89.2M). MAIA YTD gains are higher at: 57.516 vs. ACRS (16.611). MAIA has higher annual earnings (EBITDA): -22.34M vs. ACRS (-65.32M). ACRS has more cash in the bank: 95.9M vs. MAIA (10.9M). ACRS has higher revenues than MAIA: ACRS (15.7M) vs MAIA (0).
ACRSMAIAACRS / MAIA
Capitalization381M89.2M427%
EBITDA-65.32M-22.34M292%
Gain YTD16.61157.51629%
P/E RatioN/AN/A-
Revenue15.7M0-
Total Cash95.9M10.9M880%
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ACRS: Fundamental Ratings
ACRS
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRSMAIA
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 7 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 19 days ago
80%
Bullish Trend 6 days ago
89%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ACRS
Daily Signal:
Gain/Loss:
MAIA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLPRF0.290.01
+3.15%
DLP RES INC.
CHEAF0.63N/A
N/A
China Eastern Airlines Corp. Ltd.
SOLTF5.44N/A
N/A
Nxera Pharma Co.,Ltd.
EDDYF0.07N/A
N/A
EDISON LITHIUM CORP.
PEGRY15.05-0.20
-1.32%
Pennon Group PLC

ACRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with STRRP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+2.33%
STRRP - ACRS
52%
Loosely correlated
N/A
RAPT - ACRS
49%
Loosely correlated
+0.09%
MYNZ - ACRS
40%
Loosely correlated
-4.03%
UFPT - ACRS
39%
Loosely correlated
+1.77%
OCUL - ACRS
39%
Loosely correlated
-8.14%
More

MAIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAIA has been loosely correlated with CRVS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MAIA jumps, then CRVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
+0.84%
CRVS - MAIA
36%
Loosely correlated
-1.15%
ACRS - MAIA
32%
Poorly correlated
+2.33%
TERN - MAIA
27%
Poorly correlated
+1.17%
GLMD - MAIA
27%
Poorly correlated
-5.33%
DFTX - MAIA
27%
Poorly correlated
-2.09%
More